ANI Pharmaceuticals PEG Ratio

ANI Pharmaceuticals (ANIP) currently reports a PEG ratio of 6.86. That is above the Healthcare sector average of 2.56. Use the charts on this page to explore ANI Pharmaceuticals's PEG ratio history and peer comparisons.

ANI Pharmaceuticals's PEG ratio of 6.86 is higher than the Healthcare sector average of 2.56. That is roughly 168.2% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates ANI Pharmaceuticals's market price to a fundamental measure such as earnings, sales, or book value. At 6.86, ANIP can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 6.86, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 2.56. From there, open related valuation or income-statement pages for ANI Pharmaceuticals, and consider following ANIP for alerts when major investors trade the stock.

ANI Pharmaceuticals is classified in the Healthcare sector. On PEG ratio, it currently shows 6.86 versus a sector average near 2.56. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ANIP with unrelated industries.